Teva Pharmaceutical eyes more acquisitions

May 5 Reuters – Teva Pharmaceutical Industries TEVA.O, the world’s biggest generic drugmaker, is in the market for more acquisitions following its purchase of rival Barr, Teva Chief Financial Officer Eyal Desheh said on Tuesday.

Desheh told Reuters, following the release of first-quarter results, that the first quarter was expected to be the weakest this year for launches of new products.

“The fourth quarter is supposed to be the most actice in new launches and in between we expect improvement from one quarter to the next,” he said.

Desheh also said Teva TEVA.TA was seeing only marginal impact from the global economic slowdown, and this was being offset by customers seeking generic drugs that are cheaper than branded products.

via Reuters

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: